Table 1.
Demographic and Clinical Information of Schizophrenia Patients
| Schizophrenia Patients (Cross Sectional, n = 91) | Schizophrenia Patients (rTMS Treatment) | |||
|---|---|---|---|---|
| Active Group (n = 26) | Sham Group (n = 26) | Statistics/P-Value | ||
| Age (years) | 26.0 ± 7.90 | 26.4 ± 8.63 | 26.5 ± 6.65 | .05/.96 |
| Gender (m/f) | 37/54 | 12 ± 14 | 13 ± 13 | .08/.78 |
| Education (years) | 12 ± 2.68 | 12.4 ± 2.89 | 12.0 ± 2.74 | .49/.62 |
| Disease Duration (years) | 6.1 ± 4.95 | 6.7 ± 4.66 | 6.4 ± 5.40 | .18/.86 |
| PANSS | 69.9 ± 16.90 | 73.4 ± 18.34 | 71.4 ± 16.98 | .40/.69 |
| HAMA | 5.7 ± 3.20 | 5.0 ± 2.93 | 6.1 ± 3.48 | 1.17/.25 |
| HAMD | 5.1 ± 2.92 | 4.8 ± 2.36 | 5.7 ± 3.92 | 1.07/.29 |
| Risperidone equivalent (mg) | 21.6 ± 16.39 | 22.8 ± 15.6 | 23.4 ± 21.2 | .12/.91 |
HAMA, Hamilton Anxiety Rating Scale; HAMD, Hamilton Depression Rating Scale; PANSS, the Positive and Negative Syndrome Scale; rTMS, repetitive Transcranial Magnetic Stimulation.